(Reuters) — The chief executive of embattled blood testing company Theranos Inc on Monday said the privately held firm is working diligently to rectify all of its outstanding issues involving its product and laboratory operations. Speaking before some 1,000 scientists at the American Association for Clinical Chemistry meeting in Philadelphia, Theranos CEO Elizabeth Holmes described new […]
(Reuters) — The chief executive of embattled blood testing company Theranos Inc on Monday said the privately held firm is working diligently to rectify all of its outstanding issues involving its product and laboratory operations. Speaking before some 1,000 scientists at the American Association for Clinical Chemistry meeting in Philadelphia, Theranos CEO Elizabeth Holmes described new […]
Share this Article
Recommended